Revisions of 'Osteogenesis imperfecta and bisphosphonate lines'
-
Revision 8 - created 8 months ago by Ryan Thibodeau - view changesetDate: 2023-09-30 01:34:58 UTC Disclosures:
At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.
View Ryan Thibodeau's current disclosures Reviewed by: Patrick O'Shea -
Revision 7 - created 8 months ago by Frank Gaillard - view changesetDate: 2023-09-24 07:24:14 UTC Disclosures:
At the time the revision was created Frank Gaillard had the following disclosures:
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Frank Gaillard's current disclosures Reviewed by: Joachim Feger -
Revision 6 - created 9 months ago by Karen Machang'a - view changesetDate: 2023-08-25 04:08:11 UTC Disclosures:
At the time the revision was created Karen Machang'a had no financial relationships to ineligible companies to disclose.
View Karen Machang'a's current disclosures Reviewed by: Joachim Feger -
Revision 5 - created 9 months ago by Henry Knipe - view changesetDate: 2023-08-24 22:53:34 UTC Disclosures:
At the time the revision was created Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.
View Henry Knipe's current disclosures Reviewed by: Joachim Feger -
Revision 4 - created 9 months ago by Kayleigh Louise Wood - view changesetDate: 2023-08-17 06:10:04 UTC Disclosures:
At the time the revision was created Kayleigh Louise Wood had no financial relationships to ineligible companies to disclose.
View Kayleigh Louise Wood's current disclosures Reviewed by: Henry Knipe -
Revision 3 - created 9 months ago by Arlene Campos - view changesetDate: 2023-08-07 02:57:45 UTC Disclosures:
At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.
View Arlene Campos's current disclosures Reviewed by: Henry Knipe -
Revision 2 - created 10 months ago by Kayleigh Louise Wood - view changesetDate: 2023-08-06 11:38:01 UTC Disclosures:
At the time the revision was created Kayleigh Louise Wood had no financial relationships to ineligible companies to disclose.
View Kayleigh Louise Wood's current disclosures Reviewed by: Arlene Campos -
Revision 1 - created over 1 year ago by Kayleigh Louise Wood - view changesetDate: 2022-10-27 09:06:19 UTC Disclosures:
At the time the revision was created Kayleigh Louise Wood had no recorded disclosures.
View Kayleigh Louise Wood's current disclosures Reviewed by: Henry Knipe
Unfortunately some older revisions may not be able to be viewed or restored.
Radiopaedia.org is a collaborative effort and anyone can contribute. Every revision counts. Learn more about contributing.
Each article also undergoes a sophisticated editorial process to ensure the high quality of Radiopaedia.org. Through open contributions by many different medical professionals, editorial oversight from our excellent editorial and expert review boards, and continual moderation, we can continue to provide the best, free radiology resource online.